J&J accepts EU for Dual Energy Thermocool Smarttouch


Cardiac arrhythmia on diagnosis list, medical concept

Michail_Petrov-96/iStock via Getty Images

Johnson & Johnson (NYSE:JNJ) has received EU approval for its Dual Energy Thermocool Smarttouch SF catheter for the treatment of cardiac arrhythmias.

The product is an irrigated contact force sensing catheter powered by J&J’s (NYSE:JNJ) Trupulse Generator and is completely



Source link

  • Related Posts

    Wildfires Expose California’s Insurance Crisis; Meta, Amazon melts DEI; and the IRS describes tax season

    Heritage economist EJ Antoni analyzes the December work report on ‘Earning money’. Stocks fall after stronger-than-expected jobs report sparks fresh headwinds for Federal Reserve -President-elect Trump attacked President Biden after…

    financial restructuring in divorce

    Unlock Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories in this weekly newsletter. January is the “month of divorce”, according to the marketing departments…

    Leave a Reply

    Your email address will not be published. Required fields are marked *